Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
I came across this interesting infographic by [x]cube labs earlier today and thought I’d share it with you. 
No comment yet.
Sign up to comment
Scoop.it!
Le 14 novembre dernier, le Conseil National de l’Ordre des Médecins (CNOM) a organisé une journée de débats sur le thème « Ethique dans les usages du numérique en santé ». Revivez ces échange...
Scoop.it!
Aging baby boomers think they have found the fountain of youth in the testosterone prescription products that are being marketed by pharma companies. Via Pharmacomptoir / Corinne Thuderoz
Scoop.it!
From Business Insider's Ignition Conference 2012. "The Future of Business" presented by Henry Blodget. Via Pharmacomptoir / Corinne Thuderoz
Scoop.it!
Pharmaceutical companies lose an estimated $188 billion annually in revenues in the U.S. because patients fail to take their prescribed medications, according to a study by consulting firm Capgemini.
Even for the countries in Western Europe such as the Netherlands where medication is fully covered, adherence is still a major concern and growing issue.
In the U.S. Medicare payment reforms aim to place an emphasis on preventive health measures affecting other sectors in health care, pharmaceutical companies are no longer alone in facing poor medication adherence.
The question is are these false promises or actual achievable objectives because of wrong targeting?
Via Lionel Reichardt / le Pharmageek
Scoop.it!
Les entreprises ne doivent pas se contenter de faire du marketing digital. Elles doivent aller plus loin, transformer leur business model, impliquer les clients, fournisseurs et partenaires.
Scoop.it!
À l'approche des fêtes de fin d'année, l'enseigne Fnac propose à ses fans de partager leur 'FnacWishList' avec leur famille et leurs amis sur Facebook. Une bonne façon pour l'entourage de ne pas se tromper de cadeau.
Scoop.it!
Découvert par hasard en cliquant sur une bannière: un nouveau produit appelé "Siga Red" habillé comme un paquet de cigarettes mais vendu par Pfizer (les médocs). En principe il faut avoir 18ans pour commander et la campagne est orchestrée par Ogilvy.
Le produit promet « un nouveau mélange et un nouveau gout », il faut s’inscrire via Twitter ou Facebook pour recevoir un échantillon gratuit… (il est quand même possible de commander sans donner accès à ses réseaux sociaux).
Qui tente pour découvrir ce qui se cache derrière ? Via Geoffrey Laloux
|
Scoop.it!
RT @kiwfranc : Création de la communauté "santé 2.0" sur Google+ http://t.co/ZKxlgCVi #hcsmeufr #esante. Vous êtes cordialement invités ! Via Mélanie Toussaint
Scoop.it!
Si les médias sociaux peuvent être considérés comme un relai de données médicales comme un autre, il est impossible de compter dessus comme un canal fiable. En effet, de nombreux facteurs peuvent impacter cette diffusion. - Un environnement parfois favorable - Le bouche à oreille reste un canal puissant Via Bérénice LOUIS
Scoop.it!
Women's Health and Web 2.0. Collection of Women's Health related blogs, podcasts, slideshows, mobile applications and community sites to help you keep yourself up-to-date. (The world's best 100, curated, social media resources about women's health! Via Pharmacomptoir / Corinne Thuderoz
Scoop.it!
Pharma: from (e)detailing to physician and patient excellence, a new commercial approach.
The demand for a new commercial model in Pharma is striking. Lots of talk about social media, KAM, gaming, mobile and all kinds of excellences: customer, sales and marketing. But what's the roadmap starting from the current situation of pharma's commercial business approach, to get to a new commercial relationship for the (local affiliates) of the pharmaceutical industry to its very customers? I invite you to the scetch of this. I made this outline on the basis of having gone that road and now look back on the (very) positive results. Hold yourself to your seat: it might feel like a roller coaster! But doesn't just make that all the fun? You may challenge me ;-) but thanks for your attention anyway!
Rob
Via rob halkes, Pharmacomptoir / Corinne Thuderoz
Scoop.it!
Cegedim Relationship Management today announced the release of its thought leadership report, 2012 US Pharma Insights, which provides the results of its third annual survey of life sciences decision makers on current challenges, upcoming business developments, preferred strategies and next generation technology. Leveraging analysis from three years of responses, the report delivers a holistic view of present and future trends.
The Shape of Change in Decision Making, Industry Concerns and the Future Sustained industry concerns, evolved decision making leadership and new future strategies top 2012’s trends. Aligning with previous years’ responses, 74% of respondents ranked the changing commercial business model as their first, second or third priority of concern; followed by regulatory reform (62%) and market access (53%). Additionally, decision making leadership now sources from executive management for most technology decisions (46%); and strategy/business development for main business model/process changes (55%). Further, respondents clearly defined the following prioritized changes for the near future: increased focus on market access strategies (64%), primary sales force realignment (38%) and increased focus on managed markets (35%).
Boosts in Field Centric Tablet Usage, Preference for Apple® Mobile OS and Noteworthy Social Media Gains Surveyed executives cite continued focus on field centric tablet usage, their preferred mobile OS and social media. Eight out of ten (80%) currently use or will be using tablets, and unsurprisingly, field sales/account management (61%) account for the most active tablet users. Further, exactly half selected Apple OS as their favorite mobile platform. In terms of social media trending, the report underscores significant increases in usage between 2011 and 2012. LinkedIn (96%) and Facebook (70%) represent respondents’ leading channels with marketing (64%), PR (42%) and sales (38%) make up the most active departments. Lastly, despite minor social media budgets, those surveyed exhibited notable gains according to the report.
“The 2012 US report details exactly how and where our current industry climate is impacting strategy and operations. Respondents report strong focus on business model changes, as well as next generation and mobile technologies,” said Angela Miccoli, President of North America, Cegedim Relationship Management. “In order to further our standing as the leader in pharma CRM, data and compliance solutions, we strive to consistently monitor the pulse of the industry, and empower our customers with our proven insights and expertise.” Via Lionel Reichardt / le Pharmageek
Dan Baxter's curator insight,
December 16, 2012 10:21 AM
'Respondents highlight that tablets are already ingrained in their companies, but fully leveraging all avenues of this optimal
Scoop.it!
Une mythe circule qui veut qu'une page Facebook est une stratégie suffisante pour réussir les médias sociaux. Si tel est votre cas, alors vous devez repenser votre stratégie. Panorama en images des planètes clés de l'univers des réseaux sociaux.
Scoop.it!
E-santéUn GCS e-santé voit le jour en Languedoc RoussillonHospimedia (Abonnement)L'ARS Languedoc-Roussillon et les acteurs régionaux de santé viennent de créer un "Groupement de coopération sanitaire (GCS) e-santé".
|
